Mark Kay, M.D., Ph.D.
Mark Kay is the Dennis Farrey Family Professor in Pediatrics and a professor of genetics at Stanford University School of Medicine, where he heads the division of human gene therapy. It is out of his lab – the storied Kay Lab at Stanford Medicine – where he and his co-founders developed the core technologies that were to become LogicBio. Dr. Kay is a leading researcher and luminary in the fields of gene therapy and AAV biology, including the identification of new AAV capsids. A founder of the American Society of Gene and Cell Therapy, Dr. Kay served as the society’s president from 2005 to 2006, and was the recipient of its Outstanding Achievement Award in 2013. He is currently the editor of Human Gene Therapy and serves on the editorial boards of other peer-reviewed publications.